Join our community of smart investors

Spire announces first dividend

Spire Healthcare (SPI) has lived up to certain promises eight months on from its London IPO.
March 25, 2015

Eight months after its flotation, chief executive Rob Roger claims hospital operator Spire Healthcare (SPI) has "delivered on its promises". With the shares already up about three-quarters on the 210p offer price, investors seem to agree - though profit-taking knocked them back 6 per cent on results day.

IC TIP: Hold at 372p

At the time of the IPO last July, Spire's parent company, European private equity firm Cinven, offloaded 12 properties owned by Spire, replacing them with lease liabilities. But Mr Roger says that's "just half" of Spire's business model. To keep the group's operational gearing under control, new properties added to the estate are bought freehold.

In May, Spire completed one such acquisition - that of St Anthony's hospital in Cheam, which boasts 92 beds and four operating theatres. Spire is also building new hospitals in Manchester and Nottingham, and hopes to open a second cancer centre in Exeter after opening a radiotherapy site in Bristol last April.

As the general election approaches, Mr Roger says Spire could have more to gain from a Labour victory. He believes the party shares Spire's concern over a budgetary shortfall of £35bn in healthcare by the end of the decade, as public sector funding comes under further pressure. The NHS 'choose and book' policy - which helps drive a chunk of Spire's revenues - allows patients to opt to self-pay for procedures not readily funded by the NHS. This strategy was devised by the Blair-Brown administration of the late 1990s.

Election results aside, Spire is on track for a good 2015. Last year IPO costs distorted profits, but on an adjusted basis cash profits rose 6 per cent to £159m. The company finished the year with £424m of net debt - £10m better than analysts expected - and declared a maiden dividend worth 1.8p per share. Accounting for the dividend and debt repayments, Mr Roger says the group has around £100m in free cash for capital expenditure this year. Management are guiding investors to expect mid-to-high single-digit EPS growth in 2015.

Brokerage Numis expects pre-tax profits of £93.2m this year, giving EPS of 20.4p, up from £28.5m and 18.3p respectively in 2014.

SPIRE HEALTHCARE (SPI)
ORD PRICE:372pMARKET VALUE:£1.49bn
TOUCH:372-374p12-MONTH HIGH:393pLOW: 208p
DIVIDEND YIELD:0.5%PE RATIO:196
NET ASSET VALUE:239p*NET DEBT:44%

Year to 31 DecTurnover (£m)Pre-tax profit (£m)Earnings per share (p)Dividend per share (p)
2011**674-49.1nanil
2012**739-189.0nanil
2013765-51.940.9nil
2014856-7.01.91.8
% change+12--95-

Ex-div: 4 Jun

Payment: 30 Jun

*Includes intangible assets of £519m, or 129p a share

**Pre-IPO figures